leadf
logo-loader
viewEden Research PLC

Eden Research welcomes 'emergency use' authorisation for Cedroz in Italy

Sean Smith, chief executive of Eden Research PLC (LON:EDEN), caught up with Proactive's Andrew Scott following the announcement their commercial partner, Eastman Chemical Company, has received a 120-day "emergency use" authorisation from the Italian Ministry of Agriculture for Eden's nematicide formulation - Cedroz.

Smith says during this period, Italy and other member states will continue to process Eastman's request for the authorised use and sale of Cedroz following earlier authorisation by Malta.

Quick facts: Eden Research PLC

Price: 6.875 GBX

AIM:EDEN
Market: AIM
Market Cap: £26.15 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Eden Research PLC named herein, including the promotion by the Company of Eden Research PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

NetCents take a big step into the Australian market doing a deal with SoSure

NetCents Technology Inc (CSE: NC- OTCQB: NTTCF) Partner and Merchant Strategist Jana Nickason joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with SoSure of Australia. SoSure is a payment app that rewards users for participation using cryptocurrency. Nickason...

1 hour, 1 minute ago

2 min read